Literature DB >> 18539643

Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden.

Andrea Geistanger1, Sabine Arends, Christoph Berding, Tadao Hoshino, Jan-Olof Jeppsson, Randie Little, Carla Siebelder, Cas Weykamp.   

Abstract

BACKGROUND: The American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD)/International Diabetes Federation (IDF)/IFCC Consensus Statement on the worldwide standardization of HbA(1c) states that "... [HbA(1c)] results are to be reported world-wide in IFCC units ... and derived NGSP units ... , using the IFCC-NGSP master equation."
METHODS: We describe statistical methods to evaluate and monitor the relationships as expressed in master equations (MEs) between the IFCC Reference Measurement procedure (IFCC-RM) and designated comparison methods (DCMs) [US National Glycohemoglobin Standardization Program (NGSP), Japanese Diabetes Society/Japanese Society for Clinical Chemistry (JDS/JSCC), and Mono-S in Sweden]. We applied these statistics, including uncertainty calculations, to 12 studies in which networks of reference laboratories participated, operating the IFCC-RM and DCMs.
RESULTS: For NGSP and Mono-S, slope, intercept, and derived percentage HbA(1c) at the therapeutic target show compliance with the respective MEs in all 12 studies. For JDS/JSCC, a slight deviation is seen in slope and derived percentage HbA(1c) in 2 of the 12 studies. Using the MEs, the uncertainty in an assigned value increases from 0.42 mmol/mol HbA(1c) (IFCC-RM) to 0.47 (NGSP), 0.49 (JDS/JSCC), and 0.51 (Mono-S).
CONCLUSIONS: We describe sound statistical methods for the investigation of relations between networks of reference laboratories. Application of these statistical methods to the relationship between the IFCC-RM and DCMs in the US, Japan, and Sweden shows that they are suitable for the purpose, and the results support the applicability of the ADA/EASD/IDF/IFCC Consensus Statement on HbA1c measurement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18539643     DOI: 10.1373/clinchem.2008.103556

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  17 in total

Review 1.  The National Glycohemoglobin Standardization Program: Over 20 Years of Improving Hemoglobin A1c Measurement.

Authors:  Randie R Little; Curt Rohlfing; David B Sacks
Journal:  Clin Chem       Date:  2018-12-05       Impact factor: 8.327

2.  The implementation of international standardization of glycated hemoglobin. A "red-letter-day" for glycated hemoglobin in Italy: 1/1/11. Italian Recommendations of GLAD Working Group (A1c delegates WG).

Authors:  A Mosca; D Iafusco; F Meschi; M T Branca; M Carta; M L Genna; C B Giorda; R Ghidelli; G Ghislandi; A Lapolla; V Buondonno Lombardi; C A Lovagnini; M Marra; G Medea; A Pizzini; F Rossi; R Scalpone; G Tofini; M Trovati; M Zaninotto
Journal:  J Endocrinol Invest       Date:  2011-05-31       Impact factor: 4.256

3.  Influence of variables on hemoglobin A1c values and nonheterogeneity of hemoglobin A1c reference ranges.

Authors:  Trefor Higgins; George Cembrowski; David Tran; Erin Lim; Julie Chan
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

4.  Evaluation of turbidimetric inhibition immunoassay (TINIA) and HPLC methods for glycated haemoglobin determination.

Authors:  Sema Genc; Beyhan Omer; Esra Aycan-Ustyol; Nurhan Ince; Fatih Bal; Figen Gurdol
Journal:  J Clin Lab Anal       Date:  2012-11       Impact factor: 2.352

5.  Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS).

Authors:  N Furusyo; T Koga; M Ai; S Otokozawa; T Kohzuma; H Ikezaki; E J Schaefer; J Hayashi
Journal:  Diabetologia       Date:  2011-09-27       Impact factor: 10.122

6.  Systematic shifts in cystatin C between 2006 and 2010.

Authors:  David M Maahs; Diana Jalal; Kim McFann; Marian Rewers; Janet K Snell-Bergeon
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

7.  Analysis and Quantitation of Glycated Hemoglobin by Matrix Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry.

Authors:  Stephen J Hattan; Kenneth C Parker; Marvin L Vestal; Jane Y Yang; David A Herold; Mark W Duncan
Journal:  J Am Soc Mass Spectrom       Date:  2016-01-05       Impact factor: 3.109

8.  The serum undercarboxylated osteocalcin level and the diet of a Japanese population: results from the Kyushu and Okinawa Population Study (KOPS).

Authors:  Norihiro Furusyo; Takeshi Ihara; Takeo Hayashi; Hiroaki Ikezaki; Kazuhiro Toyoda; Eiichi Ogawa; Kyoko Okada; Mosaburo Kainuma; Masayuki Murata; Jun Hayashi
Journal:  Endocrine       Date:  2012-09-22       Impact factor: 3.633

9.  Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.

Authors:  Kazuhiro Dan; Toru Miyoshi; Makoto Nakahama; Tomofumi Mizuno; Kenzo Kagawa; Yoichiro Naito; Satoshi Kawada; Hiroshi Ito
Journal:  Cardiorenal Med       Date:  2018-03-27       Impact factor: 2.041

10.  Quality of HbA1c Measurement in Trinidad and Tobago.

Authors:  Maynika V Rastogi; Paul Ladenson; David E Goldstein; Randie R Little
Journal:  J Diabetes Sci Technol       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.